2012
DOI: 10.1530/joe-12-0351
|View full text |Cite
|
Sign up to set email alerts
|

mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells

Abstract: Regulated associated protein of mTOR (Raptor) and rapamycin-insensitive companion of mTOR (rictor) are two proteins that delineate two different mTOR complexes, mTORC1 and mTORC2 respectively. Recent studies demonstrated the role of rictor in the development and function of b-cells. mTORC1 has long been known to impact b-cell function and development. However, most of the studies evaluating its role used either drug treatment (i.e. rapamycin) or modification of expression of proteins known to modulate its acti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(24 citation statements)
references
References 40 publications
1
23
0
Order By: Relevance
“…Consistent with this idea and the fact that REDD1 acts to negatively regulate mTORC1, β cell failure has been shown to coincide with mTORC1 hyperactivation, an effect demonstrated in mice harbouring a β cell-specific deletion of TSC2, a key negative upstream regulator of mTORC1 [80]. Conversely, disruption of mTORC1 function by silencing the expression of raptor, a key component of the mTORC1 complex, was shown to concur with increased glucose-stimulated insulin secretion and intracellular insulin content in pancreatic INS-1 cells [81]. Therefore, the anticipated hyperactivation of mTORC1 in response to a loss of REDD1 may act to reduce insulin production and secretion, as well potentiate β cell failure, as observed in the diabetic state.…”
Section: Redd1 Modulation Of Insulin Production and Secretionmentioning
confidence: 99%
“…Consistent with this idea and the fact that REDD1 acts to negatively regulate mTORC1, β cell failure has been shown to coincide with mTORC1 hyperactivation, an effect demonstrated in mice harbouring a β cell-specific deletion of TSC2, a key negative upstream regulator of mTORC1 [80]. Conversely, disruption of mTORC1 function by silencing the expression of raptor, a key component of the mTORC1 complex, was shown to concur with increased glucose-stimulated insulin secretion and intracellular insulin content in pancreatic INS-1 cells [81]. Therefore, the anticipated hyperactivation of mTORC1 in response to a loss of REDD1 may act to reduce insulin production and secretion, as well potentiate β cell failure, as observed in the diabetic state.…”
Section: Redd1 Modulation Of Insulin Production and Secretionmentioning
confidence: 99%
“…Xu et al [22] demonstrated that leucine induced translation initiation by phosphorylation of 4E-BP-1 (formerly termed PHAS-I) and S6K, through the mTORC1-signaling pathway of pancreatic β-cells. In β-cells, leucine activates mTORC1 [19,20] that regulates insulin secretion and β-cell mass expansion [23-25]. Leucine not only increases insulin secretion but also enhances insulin signaling in insulin target tissues [26].…”
Section: Introductionmentioning
confidence: 99%
“…Among the four PRExt constituents described here, only pentagalloylglucose and PEF enhanced glucose-stimulated insulin secretion. Considering functional insulin receptors are known to present in pancreatic beta cells and provide important role in regulating glucose-mediated insulin secretion; insulinotropic effect of pentagalloylglucose might result from its insulin mimetic property [2931]. On the other hand, the underlying mechanism to explain insulinotropic effect of PEF remained to be investigated.…”
Section: Discussionmentioning
confidence: 99%